We are approaching a golden cross. A catalyst like AstraZeneca Starpharma clinical trial.......for example beginning on Monday (I am not saying it is).......would nor only kick share price closer to $2, but cause our company to be in a major bull run.....
If the trial doesn't begin then......no matter......sometime next week.....we will have arrived at this golden cross
In the graphic below.....50 day average just needs to move a smidgeon above 100 day average to confirm golden cross.
SPL Price at posting:
$1.33 Sentiment: Buy Disclosure: Held
